Ageism in cancer care: A scoping review by the International Society of Geriatric Oncology (SIOG) Nursing and Allied Health Interest Group

Haase, Kristen; Sattar, Saba; Pilleron, Sophie; Lambrechts, Yentl; Hannan, Michelle; Navarrete, E; Newton, Lorelei; Kantilal, Kumud; Jin, Rana; Wal-Huisman, Hanneke van der; Strohschein, Fay J.; Pergolotti, Mackenzi; Read, Kate; Kenis, Cindy; Puts, Martine

doi:10.1016/s1879-4068(21)00371-4

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Currently, 30% of the Canadian population aged 65+ is foreign-born and this is estimated to increase to 40% by 2055 1. Both age and race can affect access to clinical trials and the intersection of these two dimensions may compound challenges faced by older adults who also identify as a racialised person 2. The protocol and rapid scoping review use the term ‘racialised’ as recommended by the Ontario Human Rights Commission 3 4.…”

Section: Introductionmentioning

confidence: 99%

“…1 Both age and race can affect access to clinical trials and the intersection of these two dimensions may compound challenges faced by older adults who also identify as a racialised person. 2 The protocol and rapid scoping review use the term ‘racialised’ as recommended by the Ontario Human Rights Commission. 3 4 The terms ‘racialised person’ or ‘racialised group’ are broad, general terms as opposed to ‘racial minority’, ‘visible minority’, ‘person of colour’ or ‘non-white’.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Access to cancer clinical trials for racialised older adults: an equity-focused rapid scoping review protocol

Li,

Alibhai,

Noel

et al. 2024

BMJ Open

View full text Add to dashboard Cite

BackgroundThe intersection of race and older age compounds existing health disparities experienced by historically marginalised communities. Therefore, racialised older adults with cancer are more disadvantaged in their access to cancer clinical trials compared with age-matched counterparts. To determine what has already been published in this area, the rapid scoping review question are: what are the barriers, facilitators and potential solutions for enhancing access to cancer clinical trials among racialised older adults?MethodsWe will use a rapid scoping review methodology in which we follow the six-step framework of Arksey and O’Malley, including a systematic search of the literature with abstract and full-text screening to be conducted by two independent reviewers, data abstraction by one reviewer and verification by a second reviewer using an Excel data abstraction sheet. Articles focusing on persons aged 18 and over who identify as a racialised person with cancer, that describe therapies/therapeutic interventions/prevention/outcomes related to barriers, facilitators and solutions to enhancing access to and equity in cancer clinical trials will be eligible for inclusion in this rapid scoping review.Ethics and disseminationAll data will be extracted from published literature. Hence, ethical approval and patient informed consent are not required. The findings of the scoping review will be submitted for publication in a peer-reviewed journal and presentation at international conferences.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%